Crossref
Antigen glycosylation broadens the immunogenicity of E2 subunit HCV vaccines
Annals of Blood · 2020
DOI: 10.21037/aob-19-77 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Blood, 2020. Verfasst von Yi-Ping Li.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Li, Y. (2020). Antigen glycosylation broadens the immunogenicity of E2 subunit HCV vaccines. Annals of Blood. https://doi.org/10.21037/aob-19-77
Vancouver
Li Y. Antigen glycosylation broadens the immunogenicity of E2 subunit HCV vaccines. Annals of Blood. 2020. doi:10.21037/aob-19-77
BibTeX
@article{Li2020,
author = {Li, Yi-Ping},
title = {Antigen glycosylation broadens the immunogenicity of E2 subunit HCV vaccines},
journal = {Annals of Blood},
year = {2020},
doi = {10.21037/aob-19-77}
}
EUVIMED